About this trial
This clinical trial tests the feasibility and how well a scheduled meditation intervention works to improve postoperative outcomes such as pain, anxiety, insomnia, stress and mobility for patients undergoing pancreatectomy. Many patients undergoing pancreatectomy surgery report clinically important fatigue, pain, and/or reduction in quality of life. Meditation is a behavioral intervention that has been studied in a variety of medical and surgical settings, where it has been associated with reductions in pain, anxiety, blood pressure, and lack of sleep, and in some cases with decreased pain and shorter length of stay. The meditation intervention using Headspace is an easily accessible and interactive way to complete scheduled meditation. This may improve postoperative outcomes for patients undergoing pancreatectomy.
Eligibility criteria
Qualifiers
Documented informed consent of the participant and/or legally authorized representative
Willing to install required apps on personal smartphone
Willing to wear a Garmin wearable device throughout the study
Age: ≥ 18 years
Disqualifiers
Participants with prior formal training in meditation or mindfulness (e.g., completion of structured courses, workshops, or certification programs)
Participants who currently engage in a structured meditation or mindfulness practice, including regular use of mobile applications (e.g., Headspace, Calm, or similar platforms) or other formalized routines
Trial design
Treatments tested in this trial
- Actigraphy
- Online Mindfulness Meditation
- Smartphone Application-based Intervention
- Survey Administration
Treatment groups
Sponsors and collaborators
City of Hope Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator